Center for Scientific Review; Notice of Closed Meetings, 36541-36542 [2014-15060]
Download as PDF
<![CDATA[
Federal Register / Vol. 79, No. 124 / Friday, June 27, 2014 / Notices
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: June 24, 2014.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–15061 Filed 6–26–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
wreier-aviles on DSK5TPTVN1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR–13–
182: Drug Abuse Dissertation Research.
Date: July 8, 2014.
Time: 11:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Mary Clare Walker, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5208,
MSC 7852, Bethesda, MD 20892, (301) 435–
1165, walkermc@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, [PAR] 14–
073 Shared Instrumentation: Review of X-ray
diffraction systems and/or NMR
spectrometers.
Date: July 14–15, 2014.
Time: 8:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Albert Wang, Scientific
Review Officer, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, Room 4146, MSC 7806, Bethesda, MD
20892, 301–435–1016, wangca@csr.nih.gov.
VerDate Mar<15>2010
15:30 Jun 26, 2014
Jkt 232001
Name of Committee: AIDS and Related
Research Integrated Review Group,
NeuroAIDS and Other End-Organ Diseases
Study Section.
Date: July 21, 2014.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Kinzie Hotel, Twenty West Kinzie
Street, Chicago, IL 60654.
Contact Person: Eduardo A. Montalvo,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5108,
MSC 7852, Bethesda, MD 20892, (301) 435–
1168, montalve@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel,
Fellowships: Biochemistry and Biophysical
Chemistry.
Date: July 21–22, 2014.
Time: 8:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: David R. Jollie, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4166,
MSC 7806, Bethesda, MD 20892, (301) 437–
7927, jollieda@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: June 23, 2014.
Carolyn A. Baum,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–15059 Filed 6–26–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
PO 00000
Frm 00086
Fmt 4703
Sfmt 4703
36541
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Cancer Immunopathology and
Immunotherapy.
Date: July 21, 2014.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Lawrence Ka-Yun Ng,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6152,
MSC 7804, Bethesda, MD 20892, 301–435–
1719, ngkl@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR Panel:
Neuropharmacology.
Date: July 21, 2014.
Time: 12:00 p.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Richard D. Crosland,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4190,
MSC 7850, Bethesda, MD 20892, 301–435–
1220, crosland@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; RFA–RM–
13–019: Broadening Experiences in Scientific
Training (DP7/BEST) Panel 2.
Date: July 24, 2014.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Lawrence E. Boerboom,
Ph.D., Chief, CVRS IRG, Center for Scientific
Review, National Institutes of Health, 6701
Rockledge Drive, Room 4130, MSC 7814,
Bethesda, MD 20892, (301) 435–8367,
boerboom@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Hypertension and Thrombosis.
Date: July 24–25, 2014.
Time: 11:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Luis Espinoza, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4140,
MSC 7814, Bethesda, MD 20892, 301–435–
0952, espinozala@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Communication and Motor
Function.
Date: July 24, 2014.
Time: 2:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
E:\FR\FM\27JNN1.SGM
27JNN1
36542
Federal Register / Vol. 79, No. 124 / Friday, June 27, 2014 / Notices
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Andrea B. Kelly, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3182,
MSC 7770, Bethesda, MD 20892, (301) 455–
1761, kellya2@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Program
Projects: Neuropharmacology.
Date: July 25, 2014.
Time: 1:00 p.m. to 3:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Richard D. Crosland,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4190,
MSC 7850, Bethesda, MD 20892, 301–435–
1220, crosland@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Molecular
Genetics.
Date: July 25, 2014.
Time: 2:30 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Cheryl M. Corsaro, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2204,
MSC 7890, Bethesda, MD 20892, (301) 435–
1045, corsaroc@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: June 24, 2014.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–15060 Filed 6–26–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
wreier-aviles on DSK5TPTVN1PROD with NOTICES
Fiscal Year (FY) 2014 Funding
Opportunity
Substance Abuse and Mental
Health Services Administration, HHS.
ACTION: Notice of intent to award a
single source grant to Link2Health
Solutions, Inc.
AGENCY:
This notice is to inform the
public that the Substance Abuse and
Mental Health Services Administration
SUMMARY:
VerDate Mar<15>2010
15:30 Jun 26, 2014
Jkt 232001
(SAMHSA) intends to award up to
$1,448,432 (total costs) for one year to
Link2Health Solutions, Inc., as a
program supplement to the National
Suicide Prevention Lifeline. The
purpose of this program is to provide
national telephonic access at any time of
the day or night to suicide prevention
and crisis intervention services through
toll-free suicide prevention hotline
numbers, including 1–800–273–TALK
(8255). Supplemental funding is being
provided for the National Suicide
Prevention Lifeline to expand and
enhance the currently funded chat and
text-based SMS services from 12 hours
a day to 24/7 coverage. The Lifeline will
continue awareness raising activities
such as, but not limited to, social media
engagement and promotion of services
that will continue to be directed
towards the suicide prevention needs of
high-risk populations identified by the
National Action Alliance for Suicide
Prevention; lesbian, gay, bisexual, or
transgender (LGBT) youth, American
Indian/Alaska Native (AI/AN), military
family members and veterans, and
suicide attempt survivors. These
services directly support the objectives
of the National Strategy for Suicide
Prevention.
Funding Opportunity Title: SM–14–
021.
Catalog of Federal Domestic
Assistance (CFDA) Number: 93.243.
Authority: Section 520A of the Public
Health Service Act, as amended, and is
financed by 2014 Prevention and Public
Health Funds (PPHF–2014).
Justification: Eligibility is limited to
Link2Health Solutions, Inc., the current
grantee for the Cooperative Agreement
for Networking, Certifying and Training
Suicide Prevention Hotlines (the
Lifeline). Under this one-year
supplemental funding, Link2Solutions,
Inc. will expand and enhance their
current grant activities to increase chat
technology infrastructure and expand
and strengthen chat coverage for
veterans, military families, suicide
attempt survivors and other high-risk
populations. Since Link2Health
Solutions is currently operating the
National Suicide Prevention Hotline,
this is the most efficient and cost
effective use of grant funds.
FOR FURTHER INFORMATION CONTACT:
Cathy Friedman, Substance Abuse and
Mental Health Services Administration,
1 Choke Cherry Road, Room 8–1097,
Rockville, MD 20857; telephone: (240)
PO 00000
Frm 00087
Fmt 4703
Sfmt 4703
276–2316; email: cathy.friedman@
samhsa.hhs.gov.
Cathy J. Friedman,
SAMHSA Public Health Analyst.
[FR Doc. 2014–15042 Filed 6–26–14; 8:45 am]
BILLING CODE 4162–20–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Fiscal Year (FY) 2014 Funding
Opportunity
Substance Abuse and Mental
Health Services Administration, HHS.
ACTION: Notice of intent to award a
single source grant to the Education
Development Center, Inc., Waltham,
MA.
AGENCY:
This notice is to inform the
public that the Substance Abuse and
Mental Health Services Administration
(SAMHSA) intends to award up to
$1,182,918 (total costs) for one year to
the Education Development Center, Inc.,
Waltham, MA, as a program supplement
to the Suicide Prevention Resource
Center. The purpose of this program
supplement is to support high-impact
objectives of the National Strategy for
Suicide Prevention (NSSP), provide
technical assistance for NSSP
implementation, and develop an
implementation plan for preventing
suicide among men in mid-life, with the
overall goal of reducing suicides and
suicidal behaviors in the nation. This
supplement represents an enhancement
of the SPRC’s capacity to carry out its
primary mission of advancing
implementation of the NSSP.
Funding Opportunity Title: SM–14–
022.
Catalog of Federal Domestic
Assistance (CFDA) Number: 93.243.
SUMMARY:
Authority: Sections 520A and 520C of the
Public Health Service Act, as amended, and
is financed by SAMHSA’s Budget Authority
and the 2014 Prevention and Public Health
Funds (PPHF–2014).
Justification: Eligibility for this
funding opportunity is limited to the
Education Development Center, Inc.,
Waltham, MA. Education Development
Center, Inc. is the current grantee for
SAMHSA’s Suicide Prevention
Resource Center and acts as the
Executive Secretariat for the National
Action Alliance for Suicide Prevention,
providing the infrastructure,
administrative support, and guidance to
its leadership, Executive Committee,
and task forces. Education Development
Center, Inc. has the infrastructure
E:\FR\FM\27JNN1.SGM
27JNN1
]]>Agencies
[Federal Register Volume 79, Number 124 (Friday, June 27, 2014)]
[Notices]
[Pages 36541-36542]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-15060]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Cancer Immunopathology and Immunotherapy.
Date: July 21, 2014.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Telephone Conference Call).
Contact Person: Lawrence Ka-Yun Ng, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6152, MSC 7804, Bethesda, MD
20892, 301-435-1719, ngkl@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; PAR Panel: Neuropharmacology.
Date: July 21, 2014.
Time: 12:00 p.m. to 2:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Telephone Conference Call).
Contact Person: Richard D. Crosland, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4190, MSC 7850, Bethesda, MD
20892, 301-435-1220, crosland@nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; RFA-RM-13-019: Broadening Experiences in Scientific Training
(DP7/BEST) Panel 2.
Date: July 24, 2014.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Lawrence E. Boerboom, Ph.D., Chief, CVRS IRG,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 4130, MSC 7814, Bethesda, MD 20892, (301) 435-
8367, boerboom@nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Hypertension and Thrombosis.
Date: July 24-25, 2014.
Time: 11:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Virtual Meeting).
Contact Person: Luis Espinoza, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 4140, MSC 7814, Bethesda, MD 20892, 301-435-
0952, espinozala@mail.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Communication and Motor Function.
Date: July 24, 2014.
Time: 2:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
[[Page 36542]]
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Virtual Meeting).
Contact Person: Andrea B. Kelly, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3182, MSC 7770, Bethesda, MD
20892, (301) 455-1761, kellya2@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Program Projects: Neuropharmacology.
Date: July 25, 2014.
Time: 1:00 p.m. to 3:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Telephone Conference Call).
Contact Person: Richard D. Crosland, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4190, MSC 7850, Bethesda, MD
20892, 301-435-1220, crosland@nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Molecular Genetics.
Date: July 25, 2014.
Time: 2:30 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Telephone Conference Call).
Contact Person: Cheryl M. Corsaro, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2204, MSC 7890, Bethesda, MD
20892, (301) 435-1045, corsaroc@csr.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: June 24, 2014.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2014-15060 Filed 6-26-14; 8:45 am]
BILLING CODE 4140-01-P
